Kulvinder Kochar Kaur, et al. “Optimizing Cardiovascular Outcome in Type 2 Diabetes Mellitus With Better Control of Diabetes Mellitus With Empigliflozin and Hypertension With Renin Angiotensin System Inhibitors and Manidipine Preferably of the Dihydropyridones”. Obesity Research, Jan. 2020, pp. 1-13, doi:10.17140/OROJ-7-141.